Recent Development of Heterocyclic Compounds with Indazole Moiety as Potential Antiparasitic Agents

Lozano, R.; Naghavi, M.; Foreman, K.; Lim, S.; Shibuya, K.; Aboyans, V.; Abraham, J.; Adair, T.; Aggarwal, R.; Ahn, S.Y.; Alvarado, M.; Anderson, H.R.; Anderson, L.M.; Andrews, K.G.; Atkinson, C.; Baddour, L.M.; Barker-Collo, S.; Bartels, D.H.; Bell, M.L.; Benjamin, E.J.; Bennett, D.; Bhalla, K.; Bikbov, B.; Bin Abdulhak, A.; Birbeck, G.; Blyth, F.; Bolliger, I.; Boufous, S.; Bucello, C.; Burch, M.; Burney, P.; Carapetis, J.; Chen, H.; Chou, D.; Chugh, S.S.; Coffeng, L.E.; Colan, S.D.; Colquhoun, S.; Colson, K.E.; Condon, J.; Connor, M.D.; Cooper, L.T.; Corriere, M.; Cortinovis, M.; de Vaccaro, K.C.; Couser, W.; Cowie, B.C.; Criqui, M.H.; Cross, M.; Dabhadkar, K.C.; Dahodwala, N.; De Leo, D.; Degenhardt, L.; Delossantos, A.; Denenberg, J.; Des Jarlais, D.C.; Dharmaratne, S.D.; Dorsey, E.R.; Driscoll, T.; Duber, H.; Ebel, B.; Erwin, P.J.; Espindola, P.; Ezzati, M.; Feigin, V.; Flaxman, A.D.; Forouzanfar, M.H.; Fowkes, F.G.; Franklin, R.; Fransen, M.; Freeman, M.K.; Gabriel, S.E.; Gakidou, E.; Gaspari, F.; Gillum, R.F.; Gonzalez-Medina, D.; Halasa, Y.A.; Haring, D.; Harrison, J.E.; Havmoeller, R.; Hay, R.J.; Hoen, B.; Hotez, P.J.; Hoy, D.; Jacobsen, K.H.; James, S.L.; Jasrasaria, R.; Jayaraman, S.; Johns, N.; Karthikeyan, G.; Kassebaum, N.; Keren, A.; Khoo, J.P.; Knowlton, L.M.; Kobusingye, O.; Koranteng, A.; Krishnamurthi, R.; Lipnick, M.; Lipshultz, S.E.; Ohno, S.L.; Mabweijano, J.; MacIntyre, M.F.; Mallinger, L.; March, L.; Marks, G.B.; Marks, R.; Matsumori, A.; Matzopoulos, R.; Mayosi, B.M.; McAnulty, J.H.; McDermott, M.M.; McGrath, J.; Mensah, G.A.; Merriman, T.R.; Michaud, C.; Miller, M.; Miller, T.R.; Mock, C.; Mocumbi, A.O.; Mokdad, A.A.; Moran, A.; Mulholland, K.; Nair, M.N.; Naldi, L.; Narayan, K.M.; Nasseri, K.; Norman, P.; O’Donnell, M.; Omer, S.B.; Ortblad, K.; Osborne, R.; Ozgediz, D.; Pahari, B.; Pandian, J.D.; Rivero, A.P.; Padilla, R.P.; Perez-Ruiz, F.; Perico, N.; Phillips, D.; Pierce, K.; Pope, C.A., III; Porrini, E.; Pourmalek, F.; Raju, M.; Ranganathan, D.; Rehm, J.T.; Rein, D.B.; Remuzzi, G.; Rivara, F.P.; Roberts, T.; De León, F.R.; Rosenfeld, L.C.; Rushton, L.; Sacco, R.L.; Salomon, J.A.; Sampson, U.; Sanman, E.; Schwebel, D.C.; Segui-Gomez, M.; Shepard, D.S.; Singh, D.; Singleton, J.; Sliwa, K.; Smith, E.; Steer, A.; Taylor, J.A.; Thomas, B.; Tleyjeh, I.M.; Towbin, J.A.; Truelsen, T.; Undurraga, E.A.; Venketasubramanian, N.; Vijayakumar, L.; Vos, T.; Wagner, G.R.; Wang, M.; Wang, W.; Watt, K.; Weinstock, M.A.; Weintraub, R.; Wilkinson, J.D.; Woolf, A.D.; Wulf, S.; Yeh, P.H.; Yip, P.; Zabetian, A.; Zheng, Z.J.; Lopez, A.D.; Murray, C.J.; AlMazroa, M.A.; Memish, Z.A. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859), 2095-2128.
[http://dx.doi.org/10.1016/S0140-6736(12)61728-0] [PMID: 23245604]

Yi-Ting, L.; Guang-Hui, R.; You-Sheng, L.; Kun, Y.; Le-Ping, S.; Shi-Zhu, L.; Shan, L.; Tie-Wu, J. Global burden and challenges of parasitic diseases in Africa. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, 2018, 30(2), 226-231.
[http://dx.doi.org/10.16250/j.32.1374.2018020] [PMID: 29770673]

Hotez, P.J. Human parasitology and parasitic diseases: Heading towards 2050. Adv. Parasitol., 2018, 100, 29-38.
[http://dx.doi.org/10.1016/bs.apar.2018.03.002]

Singh, B.; Varikuti, S.; Halsey, G.; Volpedo, G.; Hamza, O.M.; Satoskar, A.R. Host-directed therapies for parasitic diseases. Future Med. Chem., 2019, 11(15), 1999-2018.
[http://dx.doi.org/10.4155/fmc-2018-0439] [PMID: 31390889]

Meade, T.M.; Watson, J. Parasitic Diseases. In: The Laboratory Rat; Wiley Online Books; Elsevier, 2020; pp. 569-600.
[http://dx.doi.org/10.1016/B978-0-12-814338-4.00014-3]

Gaikwad, D.D.; Chapolikar, A.D.; Devkate, C.G.; Warad, K.D.; Tayade, A.P.; Pawar, R.P.; Domb, A.J. Synthesis of indazole motifs and their medicinal importance: An overview. Eur. J. Med. Chem., 2015, 90, 707-731.
[http://dx.doi.org/10.1016/j.ejmech.2014.11.029] [PMID: 25506810]

Kerru, N.; Gummidi, L.; Maddila, S.; Gangu, K.K.; Jonnalagadda, S.B. A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules, 2020, 25(8), E1909.
[http://dx.doi.org/10.3390/molecules25081909] [PMID: 32326131]

Dong, J.; Zhang, Q.; Wang, Z.; Huang, G.; Li, S. Recent advances in the development of indazole-based anticancer agents. ChemMedChem, 2018, 13(15), 1490-1507.
[http://dx.doi.org/10.1002/cmdc.201800253] [PMID: 29863292]

Sandeep Reddy, G.; Mohanty, S.; Kumar, J.; Venteswar Rao, B. Synthesis and evaluation of anticancer activity of indazole derivatives. Russ. J. Gen. Chem., 2018, 88(11), 2394-2399.
[http://dx.doi.org/10.1134/S1070363218110233]

Ghelani, S.M.; Khunt, H.R.; Naliapara, Y.T. Design, synthesis, characterization, and antimicrobial screening of novel indazole bearing oxadiazole derivatives. J. Heterocycl. Chem., 2017, 54(1), 65-70.
[http://dx.doi.org/10.1002/jhet.2540]

Vyas, D.H.; Tala, S.D.; Akbari, J.D.; Dhaduk, M.F.; Joshi, H.S. Synthesis, antimicrobial and antitubercular activity of some cyclohexenone and indazole derivatives. Indian J. Chem. - Sect. B Org. Med. Chem., 2009, 48(10), 1405-1410.
[http://dx.doi.org/10.1002/chin.201007103]

Pérez-Villanueva, J.; Yépez-Mulia, L.; González-Sánchez, I.; Palacios-Espinosa, J.F.; Soria-Arteche, O.; Sainz-Espuñes, T.D.R.; Cerbón, M.A.; Rodríguez-Villar, K.; Rodríguez-Vicente, A.K.; Cortés-Gines, M.; Custodio-Galván, Z.; Estrada-Castro, D.B. Synthesis and biological evaluation of 2H-indazole derivatives: Towards antimicrobial and anti-inflammatory dual agents. Molecules, 2017, 22(11), E1864.
[http://dx.doi.org/10.3390/molecules22111864] [PMID: 29088121]

Kim, S.H.; Markovitz, B.; Trovato, R.; Murphy, B.R.; Austin, H.; Willardsen, A.J.; Baichwal, V.; Morham, S.; Bajji, A. Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles. Bioorg. Med. Chem. Lett., 2013, 23(10), 2888-2892.
[http://dx.doi.org/10.1016/j.bmcl.2013.03.075] [PMID: 23566519]

Lee, F.Y.; Lien, J.C.; Huang, L.J.; Huang, T.M.; Tsai, S.C.; Teng, C.M.; Wu, C.C.; Cheng, F.C.; Kuo, S.C. Synthesis of 1-benzyl-3-(5¢-hydroxymethyl-2¢-furyl)indazole analogues as novel antiplatelet agents. J. Med. Chem., 2001, 44(22), 3746-3749.
[http://dx.doi.org/10.1021/jm010001h] [PMID: 11606139]

Qin, J.; Cheng, W.; Duan, Y-T.; Yang, H.; Yao, Y. Indazole as a privileged scaffold: The derivatives and their therapeutic applications. Anticancer. Agents Med. Chem., 2021, 21(7), 839-860.
[http://dx.doi.org/10.2174/1871520620999200818160350] [PMID: 32819234]

Thangadurai, A.; Minu, M.; Wakode, S.; Agrawal, S.; Narasimhan, B. Indazole: A medicinally important heterocyclic moiety. Med. Chem. Res., 2012, 21(7), 1509-1523.
[http://dx.doi.org/10.1007/s00044-011-9631-3]

Cao, Y.; Luo, C.; Yang, P.; Li, P.; Wu, C. Indazole scaffold: A generalist for marketed and clinical drugs. Med. Chem. Res., 2021, 30(3), 501-518.
[http://dx.doi.org/10.1007/s00044-020-02665-7]

Ali, N.A.; Dar, B.A.; Pradhan, V.; Farooqui, M. Chemistry and biology of indoles and indazoles: A mini-review. Mini Rev. Med. Chem., 2013, 13(12), 1792-1800.
[http://dx.doi.org/10.2174/1389557511313120009] [PMID: 22625410]

Cankařová, N.; Hlaváč, J.; Krchňák, V. Recent synthetic approaches to 1H- and 2H-indazoles. a review. Org. Prep. Proced. Int., 2010, 42(5), 433-465.
[http://dx.doi.org/10.1080/00304948.2010.513898]

Cerecetto, H.; Gerpe, A.; González, M.; Arán, V.J.; de Ocáriz, C.O. Pharmacological properties of indazole derivatives: Recent developments. Mini Rev. Med. Chem., 2005, 5(10), 869-878.
[http://dx.doi.org/10.2174/138955705774329564] [PMID: 16250831]

Ghosh, S.; Mondal, S.; Hajra, A. Direct catalytic functionalization of indazole derivatives. Adv. Synth. Catal., 2020, 362(18), 3768-3794.
[http://dx.doi.org/10.1002/adsc.202000423]

Andrews, K.T.; Haque, A.; Jones, M.K. HDAC inhibitors in parasitic diseases. Immunol. Cell Biol., 2012, 90(1), 66-77.
[http://dx.doi.org/10.1038/icb.2011.97] [PMID: 22124373]

Hotez, P.J.; Kamath, A. Neglected tropical diseases in sub-saharan Africa: Review of their prevalence, distribution, and disease burden. PLoS Negl. Trop. Dis., 2009, 3(8), e412.
[http://dx.doi.org/10.1371/journal.pntd.0000412] [PMID: 19707588]

Andrews, K.T.; Fisher, G.; Skinner-Adams, T.S. Drug repurposing and human parasitic protozoan diseases. Int. J. Parasitol. Drugs Drug Resist., 2014, 4(2), 95-111.
[http://dx.doi.org/10.1016/j.ijpddr.2014.02.002] [PMID: 25057459]

Schmidt, A.; Beutler, A.; Snovydovych, B. Recent advances in the chemistry of indazoles. Eur. J. Org. Chem., 2008, 2008(24), 4073-4095. Available from: https://doi.org/https://doi.org/10.1002/ejoc.200800227
[http://dx.doi.org/10.1002/ejoc.200800227]

Aguilera-Venegas, B.; Olea-Azar, C.; Arán, V.J.; Speisky, H. Indazoles: a new top seed structure in the search of efficient drugs against Trypanosoma cruzi. Future Med. Chem., 2013, 5(15), 1843-1859.
[http://dx.doi.org/10.4155/fmc.13.144] [PMID: 24144415]

Shoji, Y.; Hari, Y.; Aoyama, T. Facile synthesis of 3-Trimethylsilylindazoles by [3+2]cycloaddition reaction of lithium trimethylsilyldiazomethane with benzynes. Tetrahedron Lett., 2004, 45(8), 1769-1771.
[http://dx.doi.org/10.1016/j.tetlet.2003.12.086]

Peruncheralathan, S.; Khan, T.A.; Ila, H.; Junjappa, H. α-Oxoketene dithioacetals mediated heteroaromatic annulation protocol for benzoheterocycles: An efficient regiocontrolled synthesis of highly substituted and annulated indazoles. Tetrahedron, 2004, 60(15), 3457-3464.
[http://dx.doi.org/10.1016/j.tet.2004.02.029]

Correa, A.; Tellitu, I.; Domínguez, E.; SanMartin, R. Novel alternative for the N-S bond formation and its application to the synthesis of benzisothiazol-3-ones. Org. Lett., 2006, 8(21), 4811-4813.
[http://dx.doi.org/10.1021/ol061867q] [PMID: 17020309]

Zhang, Z.; Huang, Y.; Huang, G.; Zhang, G.; Liu, Q. [Bis-(Trifluoroacetoxy)iodo]benzene-mediated oxidative direct amination C-N bond formation: Synthesis of 1H-indazoles. J. Heterocycl. Chem., 2017, 54(4), 2426-2433.
[http://dx.doi.org/10.1002/jhet.2839]

Li, H.; Li, P.; Wang, L. Direct access to acylated azobenzenes via Pd-catalyzed C-H functionalization and further transformation into an indazole backbone. Org. Lett., 2013, 15(3), 620-623.
[http://dx.doi.org/10.1021/ol303434n] [PMID: 23343496]

Moustafa, A.; Malakar, C.; Aljaar, N.; Merisor, E.; Conrad, J.; Beifuss, U. Microwave-assisted molybdenum-catalyzed reductive cyclization of o-nitrobenzylidene amines to 2-Aryl-2H-indazoles. Synlett, 2013, 24(12), 1573-1577.
[http://dx.doi.org/10.1055/s-0033-1339195]

Nykaza, T.V.; Harrison, T.S.; Ghosh, A.; Putnik, R.A.; Radosevich, A.T. A biphilic phosphetane catalyzes N-N bond-forming cadogan heterocyclization via PIII/PV═O Redox Cycling. J. Am. Chem. Soc., 2017, 139(20), 6839-6842.
[http://dx.doi.org/10.1021/jacs.7b03260] [PMID: 28489354]

Genung, N.E.; Wei, L.; Aspnes, G.E. Regioselective synthesis of 2H-indazoles using a mild, one-pot condensation-Cadogan reductive cyclization. Org. Lett., 2014, 16(11), 3114-3117.
[http://dx.doi.org/10.1021/ol5012423] [PMID: 24848311]

Zhu, J.S.; Kraemer, N.; Li, C.J.; Haddadin, M.J.; Kurth, M.J. Photochemical preparation of 1,2-dihydro-3 H-indazol-3-ones in aqueous solvent at room temperature. J. Org. Chem., 2018, 83(24), 15493-15498.
[http://dx.doi.org/10.1021/acs.joc.8b02356] [PMID: 30468072]

Gerpe, A.; Aguirre, G.; Boiani, L.; Cerecetto, H.; González, M.; Olea-Azar, C.; Rigol, C.; Maya, J.D.; Morello, A.; Piro, O.E.; Arán, V.J.; Azqueta, A.; de Ceráin, A.L.; Monge, A.; Rojas, M.A.; Yaluff, G. Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies. Bioorg. Med. Chem., 2006, 14(10), 3467-3480.
[http://dx.doi.org/10.1016/j.bmc.2006.01.007] [PMID: 16483783]

Ibáñez-Escribano, A.; Nogal-Ruiz, J.J.; Gómez-Barrio, A.; Arán, V.J.; Escario, J.A. in vitro trichomonacidal activity and preliminary in silico chemometric studies of 5-nitroindazolin-3-one and 3-alkoxy-5-nitroindazole derivatives. Parasitology, 2016, 143(1), 34-40.
[http://dx.doi.org/10.1017/S0031182015001419] [PMID: 26525913]

Muro, B.; Reviriego, F.; Navarro, P.; Marín, C.; Ramírez-Macías, I.; Rosales, M.J.; Sánchez-Moreno, M.; Arán, V.J. New perspectives on the synthesis and antichagasic activity of 3-alkoxy-1-alkyl-5-nitroindazoles. Eur. J. Med. Chem., 2014, 74, 124-134.
[http://dx.doi.org/10.1016/j.ejmech.2013.12.025] [PMID: 24448422]

Arán, V.J.; Ochoa, C.; Boiani, L.; Buccino, P.; Cerecetto, H.; Gerpe, A.; González, M.; Montero, D.; Nogal, J.J.; Gómez-Barrio, A.; Azqueta, A.; López de Ceráin, A.; Piro, O.E.; Castellano, E.E. Synthesis and biological properties of new 5-nitroindazole derivatives. Bioorg. Med. Chem., 2005, 13(9), 3197-3207.
[http://dx.doi.org/10.1016/j.bmc.2005.02.043] [PMID: 15809155]

Boiani, L.; Gerpe, A.; Arán, V.J.; Torres de Ortiz, S.; Serna, E.; Vera de Bilbao, N.; Sanabria, L.; Yaluff, G.; Nakayama, H.; Rojas de Arias, A.; Maya, J.D.; Morello, J.A.; Cerecetto, H.; González, M. in vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles. Eur. J. Med. Chem., 2009, 44(3), 1034-1040.
[http://dx.doi.org/10.1016/j.ejmech.2008.06.024] [PMID: 18706738]

Marín, C.; Ramírez-Macías, I.; Rosales, M.J.; Muro, B.; Reviriego, F.; Navarro, P.; Arán, V.J.; Sánchez-Moreno, M. in vitro leishmanicidal activity of 1,3-disubstituted 5-nitroindazoles. Acta Trop., 2015, 148, 170-178.
[http://dx.doi.org/10.1016/j.actatropica.2015.04.028] [PMID: 25956673]

Fonseca-Berzal, C.; Escario, J.A.; Arán, V.J.; Gómez-Barrio, A. Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles. Parasitol. Res., 2014, 113(3), 1049-1056.
[http://dx.doi.org/10.1007/s00436-013-3740-5] [PMID: 24435615]

Fonseca-Berzal, C.; Ibáñez-Escribano, A.; Vela, N.; Cumella, J.; Nogal-Ruiz, J.J.; Escario, J.A.; da Silva, P.B.; Batista, M.M.; Soeiro, M.N.C.; Sifontes-Rodríguez, S.; Meneses-Marcel, A.; Gómez-Barrio, A.; Arán, V.J. Antichagasic, leishmanicidal, and trichomonacidal activity of 2-benzyl-5-nitroindazole-derived amines. ChemMedChem, 2018, 13(12), 1246-1259.
[http://dx.doi.org/10.1002/cmdc.201800084] [PMID: 29624912]

El Ghozlani, M.; Bouissane, L.; Berkani, M.; Mojahidi, S.; Allam, A.; Menendez, C.; Cojean, S.; Loiseau, P.M.; Baltas, M.; Rakib, E.M. Synthesis and biological evaluation against Leishmania donovani of novel hybrid molecules containing indazole-based 2-pyrone scaffolds. MedChemComm, 2018, 10(1), 120-127.
[http://dx.doi.org/10.1039/C8MD00475G] [PMID: 30774860]

Vega, M.C.; Rolón, M.; Montero-Torres, A.; Fonseca-Berzal, C.; Escario, J.A.; Gómez-Barrio, A.; Gálvez, J.; Marrero-Ponce, Y.; Arán, V.J. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug. Eur. J. Med. Chem., 2012, 58, 214-227.
[http://dx.doi.org/10.1016/j.ejmech.2012.10.009] [PMID: 23124218]

Harrison, J.R.; Brand, S.; Smith, V.; Robinson, D.A.; Thompson, S.; Smith, A.; Davies, K.; Mok, N.; Torrie, L.S.; Collie, I.; Hallyburton, I.; Norval, S.; Simeons, F.R.C.; Stojanovski, L.; Frearson, J.A.; Brenk, R.; Wyatt, P.G.; Gilbert, I.H.; Read, K.D. A molecular hybridization approach for the design of potent, highly selective, and brain-penetrant N -myristoyltransferase inhibitors. J. Med. Chem., 2018, 61(18), 8374-8389.
[http://dx.doi.org/10.1021/acs.jmedchem.8b00884] [PMID: 30207721]

Martín-Escolano, R.; Aguilera-Venegas, B.; Marín, C.; Martín-Montes, Á.; Martín-Escolano, J.; Medina-Carmona, E.; Arán, V.J.; Sánchez-Moreno, M. Synthesis and biological in vitro and in vivo evaluation of 2-(5-nitroindazol-1-yl)ethylamines and related compounds as potential therapeutic alternatives for Chagas disease. ChemMedChem, 2018, 13(19), 2104-2118.
[http://dx.doi.org/10.1002/cmdc.201800512] [PMID: 30098232]

Díaz-Urrutia, C.A.; Olea-Azar, C.A.; Zapata, G.A.; Lapier, M.; Mura, F.; Aguilera-Venegas, B.; Arán, V.J.; López-Múñoz, R.A.; Maya, J.D. Biological and chemical study of fused tri- and tetracyclic indazoles and analogues with important antiparasitic activity. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2012, 95, 670-678.
[http://dx.doi.org/10.1016/j.saa.2012.04.076] [PMID: 22584127]

Rodríguez, J.; Gerpe, A.; Aguirre, G.; Kemmerling, U.; Piro, O.E.; Arán, V.J.; Maya, J.D.; Olea-Azar, C.; González, M.; Cerecetto, H. Study of 5-nitroindazoles’ anti-Trypanosoma cruzi mode of action: Electrochemical behaviour and ESR spectroscopic studies. Eur. J. Med. Chem., 2009, 44(4), 1545-1553.
[http://dx.doi.org/10.1016/j.ejmech.2008.07.018] [PMID: 18762357]

Rodríguez, J.; Arán, V.J.; Boiani, L.; Olea-Azar, C.; Lavaggi, M.L.; González, M.; Cerecetto, H.; Maya, J.D.; Carrasco-Pozo, C.; Cosoy, H.S. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies. Bioorg. Med. Chem., 2009, 17(24), 8186-8196.
[http://dx.doi.org/10.1016/j.bmc.2009.10.030] [PMID: 19900812]

Rodríguez-Villar, K.; Yépez-Mulia, L.; Cortés-Gines, M.; Aguilera-Perdomo, J.D.; Quintana-Salazar, E.A.; Olascoaga Del Angel, K.S.; Cortés-Benítez, F.; Palacios-Espinosa, J.F.; Soria-Arteche, O.; Pérez-Villanueva, J. Synthesis, antiprotozoal activity, and cheminformatic analysis of 2-phenyl-2H-indazole derivatives. Molecules, 2021, 26(8), 2145.
[http://dx.doi.org/10.3390/molecules26082145] [PMID: 33917871]

Rodríguez-Villar, K.; Hernández-Campos, A.; Yépez-Mulia, L.; Sainz-Espuñes, T.D.R.; Soria-Arteche, O.; Palacios-Espinosa, J.F.; Cortés-Benítez, F.; Leyte-Lugo, M.; Varela-Petrissans, B.; Quintana-Salazar, E.A.; Pérez-Villanueva, J. Design, synthesis and anticandidal evaluation of indazole and pyrazole derivatives. Pharmaceuticals (Basel), 2021, 14(3), 1-19.
[http://dx.doi.org/10.3390/ph14030176] [PMID: 33668364]

Kumar, K.P.; Vedavathi, P.; Subbaiah, K.V.; Reddy, D.V.R.; Raju, C.N. Design, synthesis, spectral characterization and bioactivity evaluation of new sulfonamide and carbamate derivatives of 5-nitro-1H-indazole. Org. Commun., 2017, 10(3), 239-249.
[http://dx.doi.org/10.25135/acg.oc.24.17.05.023]

Du, S.; Lu, H.; Yang, D.; Li, H.; Gu, X.; Wan, C.; Jia, C.; Wang, M.; Li, X.; Qin, Z. Synthesis, antifungal activity and QSAR of some novel carboxylic acid amides. Molecules, 2015, 20(3), 4071-4087.
[http://dx.doi.org/10.3390/molecules20034071] [PMID: 25749678]

Abbady, M.S.; Youssef, M.S.K. Synthesis and biological activity of some new pyridines, pyrans, and indazoles containing pyrazolone moiety. Med. Chem. Res., 2014, 23(7), 3558-3568.
[http://dx.doi.org/10.1007/s00044-014-0935-y]

Faidallah, H.M.; Khan, K.A.; Rostom, S.A.F.; Asiri, A.M. Synthesis and in vitro antitumor and antimicrobial activity of some 2,3-diaryl-7-methyl-4,5,6,7-tetrahydroindazole and 3,3a,4,5,6,7-hexahydroindazole derivatives. J. Enzyme Inhib. Med. Chem., 2013, 28(3), 495-508.
[http://dx.doi.org/10.3109/14756366.2011.653354] [PMID: 22329488]

Samadhiya, P.; Sharma, R.; Srivastava, S.K.; Srivastava, S.D. Synthesis of 2-azetidinone derivatives of 6-nitro-1h-indazole and their biological importance. Quim. Nova, 2012, 35(5), 914-919.
[http://dx.doi.org/10.1590/S0100-40422012000500010]

López-Vallejo, F.; Castillo, R.; Yépez-Mulia, L.; Medina-Franco, J.L. Benzotriazoles and indazoles are scaffolds with biological activity against Entamoeba histolytica. J. Biomol. Screen., 2011, 16(8), 862-868.
[http://dx.doi.org/10.1177/1087057111414902] [PMID: 21821786]

Anwar, A.; Mungroo, M.R.; Khan, S.; Fatima, I.; Rafique, R. Kanwal; Khan, K.M.; Siddiqui, R.; Khan, N.A. Novel azoles as antiparasitic remedies against brain-eating amoebae. Antibiotics (Basel), 2020, 9(4), 188.
[http://dx.doi.org/10.3390/antibiotics9040188] [PMID: 32316387]

Guha, R. On exploring structure-activity relationships. Methods Mol. Biol., 2013, 993, 81-94.
[http://dx.doi.org/10.1007/978-1-62703-342-8_6] [PMID: 23568465]

Phatak, S.S.; Stephan, C.C.; Cavasotto, C.N. High-throughput and in silico screenings in drug discovery. Expert Opin. Drug Discov., 2009, 4(9), 947-959.
[http://dx.doi.org/10.1517/17460440903190961] [PMID: 23480542]

Shou, W.Z. Current status and future directions of high-throughput ADME screening in drug discovery. J. Pharm. Anal., 2020, 10(3), 201-208.
[http://dx.doi.org/10.1016/j.jpha.2020.05.004] [PMID: 32612866]

Mayr, L.M.; Bojanic, D. Novel trends in high-throughput screening. Curr. Opin. Pharmacol., 2009, 9(5), 580-588.
[http://dx.doi.org/10.1016/j.coph.2009.08.004] [PMID: 19775937]

Vincendeau, P.; Gobert, A.P.; Daulouède, S.; Moynet, D.; Mossalayi, M.D. Arginases in parasitic diseases. Trends Parasitol., 2003, 19(1), 9-12.
[http://dx.doi.org/10.1016/S1471-4922(02)00010-7] [PMID: 12488215]

McKerrow, J.H. Update on drug development targeting parasite cysteine proteases. PLoS Negl. Trop. Dis., 2018, 12(8), e0005850.
[http://dx.doi.org/10.1371/journal.pntd.0005850] [PMID: 30138309]

Siqueira-Neto, J.L.; Debnath, A.; McCall, L.I.; Bernatchez, J.A.; Ndao, M.; Reed, S.L.; Rosenthal, P.J. Cysteine proteases in protozoan parasites. PLoS Negl. Trop. Dis., 2018, 12(8), e0006512.
[http://dx.doi.org/10.1371/journal.pntd.0006512] [PMID: 30138453]

Canduri, F.; Perez, P.C.; Caceres, R.A.; de Azevedo, W.F., Jr Protein kinases as targets for antiparasitic chemotherapy drugs. Curr. Drug Targets, 2007, 8(3), 389-398.
[http://dx.doi.org/10.2174/138945007780058979] [PMID: 17348832]

Pink, R.; Hudson, A.; Mouriès, M.A.; Bendig, M. Opportunities and challenges in antiparasitic drug discovery. Nat. Rev. Drug Discov., 2005, 4(9), 727-740.
[http://dx.doi.org/10.1038/nrd1824] [PMID: 16138106]

Loureiro, I.; Faria, J.; Santarem, N.; Smith, T.K.; Tavares, J.; Cordeiro-da-Silva, A. Potential drug targets in the pentose phosphate pathway of trypanosomatids. Curr. Med. Chem., 2018, 25(39), 5239-5265.
[http://dx.doi.org/10.2174/0929867325666171206094752] [PMID: 29210635]

D’Ambrosio, K.; Supuran, C.T.; De Simone, G. Are carbonic anhydrases suitable targets to fight protozoan parasitic diseases? Curr. Med. Chem., 2018, 25(39), 5266-5278.
[http://dx.doi.org/10.2174/0929867325666180326160121] [PMID: 29589529]

Zhang, C.H.; Zhu, H.M. Advances in researches on β-carbonic anhydrases as anti-parasitic drug targets. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, 2016, 28(1), 99-102.
[http://dx.doi.org/10.16250/j.32.1374.2015224] [PMID: 27356420]

Wang, Z.; Schaffer, N.E.; Kliewer, S.A.; Mangelsdorf, D.J. Nuclear receptors: Emerging drug targets for parasitic diseases. J. Clin. Invest., 2017, 127(4), 1165-1171.
[http://dx.doi.org/10.1172/JCI88890] [PMID: 28165341]

Zheng, W. Sirtuins as emerging anti-parasitic targets. Eur. J. Med. Chem., 2013, 59, 132-140.
[http://dx.doi.org/10.1016/j.ejmech.2012.11.014] [PMID: 23220641]

de Moraes, J.; Geary, T.G. FDA-approved antiparasitic drugs in the 21st century: A success for helminthiasis? Trends Parasitol., 2020, 36(7), 573-575.
[http://dx.doi.org/10.1016/j.pt.2020.04.005] [PMID: 32387059]

New drugs approval report 2020, U.S. Food and drug administration. 2020. Available from: https://www.fda.gov/media/144982/download

Navarro, M.; Visbal, G. Metal-Based Antiparasitic Therapeutics.Trace Metals and Infectious Diseases; MIT Press: Cambridge, MA, 2016, pp. 161-172.
[http://dx.doi.org/10.7551/mitpress/9780262029193.003.0014]

Folliero, V.; Zannella, C.; Chianese, A.; Stelitano, D.; Ambrosino, A.; De Filippis, A.; Galdiero, M.; Franci, G.; Galdiero, M. Application of dendrimers for treating parasitic diseases. Pharmaceutics, 2021, 13(3), 1-22.
[http://dx.doi.org/10.3390/pharmaceutics13030343] [PMID: 33808016]

Kayser, O.; Kiderlen, A.F.; Croft, S.L. Natural products as antiparasitic drugs. Parasitol. Res., 2003, 90(0)(Suppl. 2), S55-S62.
[http://dx.doi.org/10.1007/s00436-002-0768-3] [PMID: 12937967]

Nweze, J.A.; Mbaoji, F.N.; Li, Y.M.; Yang, L.Y.; Huang, S.S.; Chigor, V.N.; Eze, E.A.; Pan, L.X.; Zhang, T.; Yang, D.F. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: A review of recent articles. Infect. Dis. Poverty, 2021, 10(1), 9.
[http://dx.doi.org/10.1186/s40249-021-00796-6] [PMID: 33482912]

Zumla, A.; Rao, M.; Wallis, R.S.; Kaufmann, S.H.E.; Rustomjee, R.; Mwaba, P.; Vilaplana, C.; Yeboah-Manu, D.; Chakaya, J.; Ippolito, G.; Azhar, E.; Hoelscher, M.; Maeurer, M. Host-directed therapies network consortium. Host-directed therapies for infectious diseases: Current status, recent progress, and future prospects. Lancet Infect. Dis., 2016, 16(4), e47-e63.
[http://dx.doi.org/10.1016/S1473-3099(16)00078-5] [PMID: 27036359]